Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants
Clinical trial NCT04079101 · COMPLETED
Trial details
- NCT number
- NCT04079101
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2019-12-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.